Startups
PharmaVentures
Edit

PharmaVentures

Trusted
http://www.pharmaventures.com/
Last activity: 13.02.2026
Active
Categories: AnalyticsBioTechDevelopmentDiagnosticsFinTechFirmHealthTechInvestmentITMedTech
PharmaVentures is a premier transaction advisory firm and a leading international company in partnering, M&A deals and strategic alliances. For 30 years, PharmaVentures has acted as advisor on over 900 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies worldwide.

PharmaVentures’ deep bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes it uniquely placed to support business in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest.

PharmaVentures’ services include:
• M&A (divestments, mergers, acquisitions, and strategic transactions)
• Licensing (in and out licensing)
• Fundraising Support
• Strategy (commercialisation, deal strategy, due diligence, market entry)
• Valuation and Positioning (licensing, M&A, and fundraising)

PharmaVentures Capital Ltd is a wholly owned subsidiary of PharmaVentures Ltd. All regulated activities are delivered through PharmaVentures Capital Ltd, which is authorised and regulated by the Financial Conduct Authority (741356).

For more details, visit https://www.pharmaventures.com
Followers
9.73K
Mentions
6

Overview

Location
United Kingdom, England, London
Employees
11-50
Founded date
1992

Mentions in press and media 6

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Nov 14, 2025Q1 INTERIM REPORT JULY – SEPT 2025Q1 INTERIM REPORT JULY – SEPT 2025 Fri, Nov 14, 2025 09:00 CET Report this content OPENING REMARKS The 2024-2025 financial year was extremely productive for Hamlet BioPharma and this trend continued into the first quarter of the financial y...
Nov 4, 2025Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operationsInhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations Tue, Nov 04, 2025 08:30 CET Report this content Inhalation Sciences announced today that the company has engaged the internat...
Oct 7, 2024Faron announces Capital Markets DayFaron announces Capital Markets Day Mon, Oct 07, 2024 08:00 CET Report this content Faron Pharmaceuticals Ltd. (“Faron” or “the Company”) Faron announces Capital Markets Day to be held on 22 October 2024 Press release, 7 October 2024 TURKU,...
Aug 1, 2024GenBio Inc Partners with PharmaVentures to Accelerate Growth in the Biotechnology IndustryGenBio Inc. GenBio Inc, has engaged PharmaVentures, a premier transaction advisory firm with over 30 years of experience in Biotechnology M&A deals Never become so much of an expert that you stop gaining expertise. View life as a contin...
Jan 14, 2015PharmaVentures becomes latest Partner of One NucleusPharmaVentures becomes latest Partner of One Nucleus 14-01-2015 PharmaVentures has become the latest Partner to join forces with One Nucleus. Both PharmaVentures and One Nucleus are committed to playing an active and supportive role in assi...

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about PharmaVentures

When was PharmaVentures founded?

PharmaVentures was founded in 1992.

What has the press written about PharmaVentures?

Parsers VC has collected 6 articles mentioning PharmaVentures, among them “Q1 INTERIM REPORT JULY – SEPT 2025” (Nov 14, 2025) and “Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations” (Nov 4, 2025).

Is PharmaVentures still active?

Yes, PharmaVentures is active; its latest activity on Parsers VC dates from Feb 13, 2026.